Black Rock Inc. Abcam PLC Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$21.54 - $24.41 $1.57 Million - $1.78 Million	72,751 Added 2.13%	3,495,327 $79.1 Million
Q2 2023 Aug 11, 2023	BUY	$12.62 - $24.47 $24.5 Million - $47.5 Million	1,942,780 Added 131.29%	3,422,576 $83.8 Million
Q1 2023 May 12, 2023	SELL	$12.98 - $17.1 $66,249 - $87,278	-5,104 Reduced 0.34%	1,479,796 $19.9 Million
Q4 2022 Feb 13, 2023	BUY	$13.92 - $17.0 $1.76 Million - $2.15 Million	126,607 Added 9.32%	1,484,900 $23.1 Million
Q3 2022 Nov 14, 2022	SELL	$13.36 - $16.75 $1.48 Million - $1.85 Million	-110,665 Reduced 7.53%	1,358,293 $20.4 Million
Q2 2022 Aug 12, 2022	SELL	$12.69 - $19.25 $56,483 - $85,681	-4,451 Reduced 0.3%	1,468,958 $21.2 Million
Q1 2022 May 12, 2022	BUY	$15.5 - $23.89 $4.83 Million - $7.45 Million	311,896 Added 26.85%	1,473,409 $26.9 Million
Q4 2021 Feb 10, 2022	BUY	$20.04 - $23.84 $23.3 Million - $27.7 Million	1,160,551 Added 120639.4%	1,161,513 $27.4 Million
Q2 2021 Aug 11, 2021	BUY	$18.47 - $22.11 $17,768 - $21,269	962 New	962 $18,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.